Catherine Corrigan Sells 1,663 Shares of Exponent (NASDAQ:EXPO) Stock

Key Points

  • Catherine Corrigan, Exponent's CEO, sold 1,663 shares on January 15 at an average price of $72.52 for proceeds of $120,600.76, leaving her with 92,723 shares (a 1.76% reduction valued at about $6.72M).
  • Corrigan has made additional recent sales — 3,225 shares on December 15 at $70.74 and 4,900 shares on November 17 at $70.39 — signaling continued insider selling over the past months.
  • Exponent (market cap $3.66B) recently beat quarterly estimates, announced a $100 million share buyback, pays a $0.30 quarterly dividend (annualized $1.20, ~1.6% yield), and carries a Wall Street consensus rating of "Hold" with an average target price of $81.

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 1,663 shares of Exponent stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $72.52, for a total transaction of $120,600.76. Following the sale, the chief executive officer owned 92,723 shares of the company's stock, valued at $6,724,271.96. The trade was a 1.76% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Catherine Corrigan also recently made the following trade(s):

  • On Monday, December 15th, Catherine Corrigan sold 3,225 shares of Exponent stock. The stock was sold at an average price of $70.74, for a total transaction of $228,136.50.
  • On Monday, November 17th, Catherine Corrigan sold 4,900 shares of Exponent stock. The shares were sold at an average price of $70.39, for a total transaction of $344,911.00.

Exponent Stock Performance

Shares of NASDAQ EXPO opened at $73.39 on Wednesday. Exponent, Inc. has a 52-week low of $63.81 and a 52-week high of $97.57. The firm has a market capitalization of $3.66 billion, a price-to-earnings ratio of 35.80 and a beta of 0.81. The stock has a 50 day moving average price of $72.20 and a 200 day moving average price of $70.99.




Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings data on Thursday, October 30th. The business services provider reported $0.55 EPS for the quarter, topping the consensus estimate of $0.50 by $0.05. Exponent had a return on equity of 24.77% and a net margin of 18.35%.The company had revenue of $147.12 million for the quarter, compared to the consensus estimate of $131.78 million. During the same period last year, the business posted $0.50 EPS. Exponent's quarterly revenue was up 9.6% on a year-over-year basis. Analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent announced that its board has authorized a share buyback program on Thursday, October 30th that allows the company to repurchase $100.00 million in shares. This repurchase authorization allows the business services provider to repurchase up to 3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board of directors believes its shares are undervalued.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Friday, December 5th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.6%. The ex-dividend date was Friday, December 5th. Exponent's payout ratio is presently 58.54%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on EXPO. William Blair raised shares of Exponent from a "market perform" rating to an "outperform" rating in a research report on Monday, November 17th. Weiss Ratings reissued a "hold (c-)" rating on shares of Exponent in a report on Wednesday, October 8th. Finally, UBS Group restated a "neutral" rating and set a $81.00 target price (up previously from $76.00) on shares of Exponent in a report on Monday, December 15th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $81.00.

Get Our Latest Analysis on EXPO

Institutional Investors Weigh In On Exponent

A number of hedge funds and other institutional investors have recently bought and sold shares of EXPO. United Services Automobile Association purchased a new position in Exponent in the first quarter worth $270,000. Jane Street Group LLC boosted its position in shares of Exponent by 1,481.0% in the 1st quarter. Jane Street Group LLC now owns 127,222 shares of the business services provider's stock worth $10,313,000 after purchasing an additional 119,175 shares in the last quarter. Strs Ohio purchased a new position in Exponent during the 1st quarter worth $316,000. Assenagon Asset Management S.A. acquired a new position in Exponent during the 2nd quarter valued at about $9,993,000. Finally, Mitchell & Pahl Private Wealth LLC raised its stake in Exponent by 14.3% in the second quarter. Mitchell & Pahl Private Wealth LLC now owns 7,666 shares of the business services provider's stock valued at $573,000 after buying an additional 957 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.

Exponent Company Profile

(Get Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company's expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Featured Articles

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Exponent?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Exponent and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles